MEB 14: Parallel importation: marketing authorisation and maintenance
Parallel import is the importation – and subsequent marketing in the Netherlands – of a medicinal product authorised elsewhere in the European Union (EU) or European Economic Area (EEA), whilst a marketing authorisation has also been granted in the Netherlands. In order to be allowed to market a parallel import product, a parallel import marketing authorisation is needed. The parallel importer can apply to the MEB for a parallel import marketing authorisation.
Download this policy document in English or in Dutch.